Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions Saved Articles My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire EnWave Signs Research and Development License Agreement, Sells Radiant Energy Vacuum Machine to University of Limerick, IrelandAuthor of the article: You can save this article by registering for free here. Or sign-in if you have an account.VANCOUVER, British Columbia, Aug. 12, 2026 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that it has signed a Research and Development License Agreement (the “Agreement”) with the University of Limerick in Ireland (“Limerick”) and has sold a small-scale Radiant Energy Vacuum (“REV™”) machine to support research, product development and academic studies utilizing EnWave’s proprietary vacuum-microwave dehydration technology.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountUnder the Agreement, Limerick will establish REV™ capabilities to provide researchers and industry participants with direct access to REV™ technology for product development, process optimization and applied research.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againThe establishment of accessible REV™ research and development hubs is an important component of EnWave’s strategy to accelerate the adoption of its technology. These hubs provide prospective commercial partners with a lower-risk and capital-efficient pathway to evaluate REV™ technology, develop new products and validate processing parameters prior to considering larger-scale commercial deployment. The Company intends to continue pursuing relationships with universities, research organizations, food innovation centres and other qualified partners that can broaden access to REV™ technology.By placing REV™ equipment within established research and innovation ecosystems, EnWave can expand the number of companies engaging with its technology while supporting a broader pipeline of potential commercial opportunities. EnWave has developed a growing global network of REV™ installations spanning commercial processors, research institutions and innovation centres, with hubs now operational in Denmark, Spain, Ireland, Germany, the US, Australia and Canada.EnWave sees significant value in expanding independent academic research involving REV™. Peer-reviewed studies can provide additional third-party validation regarding product quality, processing efficiency, nutrient retention and other potential advantages of REV™ compared to conventional drying technologies. Building a deeper body of independent scientific evidence further strengthens the value proposition supporting EnWave’s commercial efforts.EnWave’s strategy remains focused on expanding its global installed base of REV™ machinery, growing recurring royalty revenue and developing a larger pipeline of commercial opportunities through increased industry engagement with its proprietary technology.About University of LimerickThe University of Limerick (“UL”) is a leading public research university located in Limerick, Ireland, recognized for its strong focus on innovation, industry collaboration and applied research. UL conducts multidisciplinary research across food science, engineering, materials, health and other fields, working closely with industry partners to translate academic research into commercially relevant technologies and solutions. For more information on UL, please visit https://www.ul.ie/.This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.Farhad Garavand, Associate Professor in Food ScienceAbout EnWave EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV™) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.Learn more at EnWave.net.Mr. Brent Charleton, CFAPresident and CEOBrent Charleton, CFA, President and CEO at +1 (778) 378-9616E-mail: bcharleton@enwave.net Nav Dhami, CPA, CFO at +1 (604) 260-4854 E-mail: ndhami@enwave.net Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.
EnWave Signs Research and Development License Agreement, Sells Radiant Energy Vacuum Machine to University of Limerick, Ireland
Full Article
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.